References
- McCormack RT, Rittenhouse HG, Finlay JA. Molecular forms of prostate specific antigen and the human kallikrein gene family: a new era. Urology 1995;45:729–44
- Wang MC, Valenzuela LA, Murphy GP, et al. Purification of human prostate-specific antigen. Invest Urol 1979;17:159–63
- Catalona WJ, Smith DS, Ratliff TL. Measurment of prostate specific antigen in serum as a screening test for prostate cancer. Engl J Med 1991;324:1156–61
- Diamandis EP. Prostate specific antigen — new applications in breast and other cancers. Anticancer Res 1996;16:3983–4
- Diamandis EP. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997;24:275–82
- Melegos DN, Yu H, Ashok M, et al. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997;82:777–80
- Escobar-Morreale HF, Serrano-Gotarredona J, Var-ela C, et al. The increased circulating prostate-specific antigen concentrations in woman with hirsutism do not respond to acute changes in adrenal and ovarian function. J Clin Endocrinol Metab 1998; 83:2580–4
- Escobar-Morreale HF, Avila S, Sancho J. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills. J Clin Endocrinol Matab 2000;85:2488–92
- Negri C, Tosi F, Dorizzi R. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 2000;85:81–4
- Young RL, Goldzieher JW, Elkind-Hirsch K. The endocrine effects of spironolactone used as an antiandrogen. Fertil Steril 1987;48:223
- Pittaway DE, Maxson WS, Wentz AC. Spirono-lactone in combination drug therapy for unresponsive hirsutism. Fertil Steril 1985;43:878
- Mauvais-Jarvis P. Regulation of androgen receptor and 5-alpha-reductase in the skin of normal and hirsute women. J Clin Endocrinol Metab 1996;15: 307–17
- Darney PD. The androgenicity of progestins. Am J Med 1995;98:1040–110
- Yu H, Diamandis EP, Monne M, et al. Oral contraceptive-induced expression of prostate-speci-fic antigen in the female breast. J Biol Chem 1995; 270:6615–8
- Witherspoon LR, Lpeyrolerie T. Sensitive pros-tate-specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 1997;157: 1322–8